(firstQuint)A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GDC-0853 in Healthy Japanese and Caucasian Participants.

 This study will be a randomized, placebo-controlled, double-blind, single and multiple dose study.

 Approximately 32 healthy subjects will be enrolled in 4 discrete cohorts with 8 subjects per cohort.

.

 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GDC-0853 in Healthy Japanese and Caucasian Participants@highlight

The purpose of this study is to investigate the safety, tolerability, and pharmacokinetics of single and multiple oral doses of GDC-0853 in healthy Japanese and Caucasian subjects.

